Chronic mucocutaneous candidiasis (CMC) is a clinical syndrome with inborn errors of IL-17 immunity, characterizing a group of primary immunodeficiencies with persistent inflammation in mucous membranes, caused by Candida species, most often C. albicans. The gene discussed is IL17A; the disease is Chronic mucocutaneous candidosis.